F-box protein 22: A prognostic biomarker for colon cancer associated with immune infiltration and chemotherapy resistance

Figure 4 The correlation between various immune cell infiltration levels, expression of immune molecules, and F-box protein 22 expression in colon adenocarcinoma was analyzed using the Tumor Immunity Evaluation Resource 2. 0 and DNA methylation interactive visualization database platforms. A: The relationship between F-box protein 22 (FBXO22) expression and immune cell in colon adenocarcinoma (COAD); B: The relationship between FBXO22 expression and immune molecules in COAD, including immune suppressive molecules and immune stimulatory molecules; C: The relationship between FBXO22 expression and chemokine in COAD. FBXO22: F-box protein 22; TCGA: The Cancer Genome Atlas; COAD: Colon adenocarcinoma.